[Use of gastrocepin in middle-aged and elderly patients with peptic ulcer]. 1986

A M Kapitanenko, and I V Shastin, and Iu N Karnaukhov, and N D Merkur'ev, and P A Smirnov

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010276 Parasympatholytics Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. Antispasmodic,Antispasmodic Agent,Antispasmodic Drug,Antispasmodics,Parasympathetic-Blocking Agent,Parasympathetic-Blocking Agents,Parasympatholytic,Parasympatholytic Agent,Parasympatholytic Drug,Spasmolytic,Spasmolytics,Antispasmodic Agents,Antispasmodic Drugs,Antispasmodic Effect,Antispasmodic Effects,Parasympatholytic Agents,Parasympatholytic Drugs,Parasympatholytic Effect,Parasympatholytic Effects,Agent, Antispasmodic,Agent, Parasympathetic-Blocking,Agent, Parasympatholytic,Agents, Antispasmodic,Agents, Parasympathetic-Blocking,Agents, Parasympatholytic,Drug, Antispasmodic,Drug, Parasympatholytic,Drugs, Antispasmodic,Drugs, Parasympatholytic,Effect, Antispasmodic,Effect, Parasympatholytic,Effects, Antispasmodic,Effects, Parasympatholytic,Parasympathetic Blocking Agent,Parasympathetic Blocking Agents
D010437 Peptic Ulcer Ulcer that occurs in the regions of the GASTROINTESTINAL TRACT which come into contact with GASTRIC JUICE containing PEPSIN and GASTRIC ACID. It occurs when there are defects in the MUCOSA barrier. The common forms of peptic ulcers are associated with HELICOBACTER PYLORI and the consumption of nonsteroidal anti-inflammatory drugs (NSAIDS). Gastroduodenal Ulcer,Marginal Ulcer,Gastroduodenal Ulcers,Marginal Ulcers,Peptic Ulcers,Ulcer, Gastroduodenal,Ulcer, Marginal,Ulcer, Peptic,Ulcers, Gastroduodenal,Ulcers, Marginal,Ulcers, Peptic
D010890 Pirenzepine An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients. Gastrotsepin,Gastrozepin,L-S 519,LS-519,Piren-Basan,Pirenzepin,Pirenzepin Von Ct,Pirenzepin-Ratiopharm,Pirenzepine Dihydrochloride,Pyrenzepine,Ulcoprotect,Ulgescum,Dihydrochloride, Pirenzepine,LS 519,LS519,Piren Basan,Pirenzepin Ratiopharm,Von Ct, Pirenzepin
D011976 Receptors, Muscarinic One of the two major classes of cholinergic receptors. Muscarinic receptors were originally defined by their preference for MUSCARINE over NICOTINE. There are several subtypes (usually M1, M2, M3....) that are characterized by their cellular actions, pharmacology, and molecular biology. Muscarinic Acetylcholine Receptors,Muscarinic Receptors,Muscarinic Acetylcholine Receptor,Muscarinic Receptor,Acetylcholine Receptor, Muscarinic,Acetylcholine Receptors, Muscarinic,Receptor, Muscarinic,Receptor, Muscarinic Acetylcholine,Receptors, Muscarinic Acetylcholine
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D005744 Gastric Acid Hydrochloric acid present in GASTRIC JUICE. Hydrochloric Acid, Gastric,Acids, Gastric,Acids, Gastric Hydrochloric,Gastric Acids,Gastric Hydrochloric Acid,Gastric Hydrochloric Acids,Hydrochloric Acids, Gastric
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A M Kapitanenko, and I V Shastin, and Iu N Karnaukhov, and N D Merkur'ev, and P A Smirnov
January 1996, Vestnik khirurgii imeni I. I. Grekova,
A M Kapitanenko, and I V Shastin, and Iu N Karnaukhov, and N D Merkur'ev, and P A Smirnov
September 1984, Khirurgiia,
A M Kapitanenko, and I V Shastin, and Iu N Karnaukhov, and N D Merkur'ev, and P A Smirnov
August 1978, Klinicheskaia khirurgiia,
A M Kapitanenko, and I V Shastin, and Iu N Karnaukhov, and N D Merkur'ev, and P A Smirnov
April 1986, Klinicheskaia meditsina,
A M Kapitanenko, and I V Shastin, and Iu N Karnaukhov, and N D Merkur'ev, and P A Smirnov
July 1976, Khirurgiia,
A M Kapitanenko, and I V Shastin, and Iu N Karnaukhov, and N D Merkur'ev, and P A Smirnov
July 1972, Vestnik khirurgii imeni I. I. Grekova,
A M Kapitanenko, and I V Shastin, and Iu N Karnaukhov, and N D Merkur'ev, and P A Smirnov
February 1985, Khirurgiia,
A M Kapitanenko, and I V Shastin, and Iu N Karnaukhov, and N D Merkur'ev, and P A Smirnov
January 1999, Klinichna khirurhiia,
A M Kapitanenko, and I V Shastin, and Iu N Karnaukhov, and N D Merkur'ev, and P A Smirnov
January 1985, Vrachebnoe delo,
A M Kapitanenko, and I V Shastin, and Iu N Karnaukhov, and N D Merkur'ev, and P A Smirnov
November 1977, Klinicheskaia khirurgiia,
Copied contents to your clipboard!